AAAS joins the Translational Medicine family1 Laboratori de Retrovirologia, Fundació irsiCaixa Hospital Universitari Germans Trias i Pujol Ctra del Canyet s/n 08916 Badalona, and Institució Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain 2 Infectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center, and Center for Human Immunology (CHI), National Institutes of Health, Bethesda, Maryland, 20892, USA
Journal of Translational Medicine 2009, 7:32doi:10.1186/1479-5876-7-32
AbstractThe AAAS has announced the launch of Science Translational Medicine. This is further and critical recognition of this discipline and we are deeply gratified that translational medicine has risen to the level of recognition by one of the world's most prestigious scientific organizations. We believe that Science Translational Medicine will provide another valuable venue for the rapid and broad dissemination of important articles in the field and contribute to enhancing the effectiveness of translational medicine overall. It has been almost six years since we launched the Journal of Translational Medicine as an open-access journal with Biomed Central [1]. At the beginning, we faced the inevitable skepticism and received several inquires among others also from Science reporters questioning both the significance of translational medicine in today's biomedical world and the need for a new journal dedicated to it. |





on Google Scholar







author email
corresponding author email